Journal Home
Search for

Volume 4, Issue 2, Pages 52-59 (October 2006)


View previous. 4 of 13 View next.

Androgen therapy for low female libido

Mohamad S. Mahmoud, MD (Resident)aCorresponding Author Informationemail address, Michael P. Diamond, MD (Professor)bcCorresponding Author Information1email address, Richard Balon, MD (Professor)dCorresponding Author Information2email address

Libido—or sexual desire—can be affected by several factors. Sexual motivation, emotional intimacy and sexual skills of the couple, psychological and biological factors and sex hormones—including estrogens and androgens—all play roles. Decreased levels of androgens in late reproductive years contribute to the decline in sexual interest/desire in older women. Several investigators agree that androgens influence libido and behavior but not activity or response—such as lubrication and orgasm.

a Department of Obstetrics and Gynecology, Oakwood Hospital and Medical Center, Dearborn, MI

b Department of Obstetrics and Gynecology, Wayne State University

c Kamran S. Moghissi Professor, Associate Chair, Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI

d Dept Psychiatry, Wayne State University, Associate Director, Residency Training, Detroit, MI

Corresponding Author InformationDepartment of Obstetrics and Gynecology, Oakwood Hospital and Medical Center, Dearborn, MI 48123

Corresponding Author InformationDepartment of Obstetrics and Gynecology, Wayne State University, Kamran S. Moghissi Professor, Associate Chair, Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI 48201

Corresponding Author InformationDept Psychiatry, Wayne State University, Associate Director, Residency Training, Detroit, MI 48207

1 Disclosures

Dr Diamond has disclosed the following contractual support relationships: Serono, TAP, GSK, Wyeth, Merck, and Pfizer; and the following consulting relationships: Serono, Genzyme, and Kytogenics.

2 Dr. Balon has disclosed the following relationships: lecturer, GSK; Consultant, Shire Pharmaceuticals.

PII: S1546-2501(06)00025-9

doi:10.1016/j.sram.2006.08.006


View previous. 4 of 13 View next.